USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
AviGenics Inc.
Address:
111 Riverbend Rd.
411 MASSACHUSETTS AVENUE
Athens, GA 30605 2613
Phone:
(706) 227-1170
URL:
N/A
EIN:
943244869
DUNS:
967296187
Number of Employees:
33
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $579,045.00 7
SBIR Phase II $2,098,455.00 3

Award List:

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$69,555.00
Agency:
USDA
Principal Investigator:
Abstract:
N/a

Ovalbumin locus BACs for expression of biotherapeutics

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$81,461.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): With a daily production capacity of two grams of protein per egg, the chicken ovalbumin gene locus has the potential to synthesize large amounts of biopharmaceutical proteins into the eggs of transgenic hens. This phase I SBIR project will test the feasibility of… More

Oviduct locus BACs for expression of bio-therapeutics

Award Year / Program / Phase:
2004 / SBIR / Phase II
Award Amount:
$728,254.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): With a daily production of 400 to 2500 milligrams of protein per egg, the chicken ovomucoid and ovalbumin gene loci have the potential to synthesize large amounts of biopharmaceutical proteins in transgenic hens. This phase II SBIR project will test the… More

Producing humanized therapeutics in quail egg white

Award Year / Program / Phase:
2004 / SBIR / Phase I
Award Amount:
$91,727.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): This project is focused on the development of a novel transgenic avian production platform that will provide human therapeutics in a rapid, cost-effective fashion. Specifically, we intend to create transgenic Japanese quail (Coturnix Coturnix sp. japonica) that… More

Avian transgenesis via site-directed integration

Award Year / Program / Phase:
2004 / SBIR / Phase I
Award Amount:
$90,000.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): This SBIR project describes a novel method to create transgenic poultry that will produce biopharmaceutical proteins in their eggs. Poultry, including chickens and quail, are able to produce large amounts of protein in their eggs at relatively low cost.… More

Protection of Transgenic Poultry from Marek's Disease Virus by RNAi

Award Year / Program / Phase:
2005 / SBIR / Phase I
Award Amount:
$80,000.00
Agency:
USDA
Principal Investigator:
Abstract:
MDV is a herpesvirus which causes a lymphoproliferative disorder of domestic chickens. Yearly economic losses from Marek's disease (MD) total $1 billion worldwide and more than $100 million in the U.S. MDV vaccines are limited in their effectiveness since continued evolution of MDV field strains… More

Avian transgenesis via site-directed integration

Award Year / Program / Phase:
2005 / SBIR / Phase II
Award Amount:
$746,264.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): This Phase II SBIR project describes a novel method to create transgenic poultry that will produce biopharmaceutical proteins in their eggs. Chickens are able to produce large amounts of protein in their eggs at relatively low cost. We seek to harness this… More

Producing Humanized Therapeutics in Avian Egg White

Award Year / Program / Phase:
2006 / SBIR / Phase II
Award Amount:
$623,937.00
Agency:
HHS
Principal Investigator:
Leandro Christmann
Abstract:
DESCRIPTION (provided by applicant): This phase II SBIR project will test the feasibility of producing large amounts of human monoclonal antibody into transchromosomic avian egg white. We will use a full length ovomucoid genomic locus expression construct created and tested in phase I, to drive… More

Transchromosomic Hens Producing Biotherapeutic Drugs

Award Year / Program / Phase:
2006 / SBIR / Phase I
Award Amount:
$80,000.00
Agency:
USDA
Principal Investigator:
Abstract:
Basic science discoveries have led to the development of a series of human biotherapeutic drugs for the treatment of cancer and HIV as well as many other diseases. Currently there are over 400 drugs in clinical trials just for the first two diseases. The current biotherapeutics' manufacturing… More

SBIR Phase I: Production of Transgenic Poultry Resistant to Avian Influenza Infection by RNAi

Award Year / Program / Phase:
2007 / SBIR / Phase I
Award Amount:
$86,302.00
Agency:
NSF
Principal Investigator:
Abstract:
This Small Business Innovation Research (SBIR) Phase I project generates transgenic poultry resistant to avian influenza (AI) virus through RNA interference (RNAi) technology. Poultry are vulnerable to AI infections that can rapidly reach mortality rates approaching 100%. Current vaccines provide… More